Market Research Logo

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Multiple Sclerosis epidemiology, Multiple Sclerosis diagnosed patients, and Multiple Sclerosis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Sclerosis derived from epidemiological analysis, percentage of patients diagnosed with Multiple Sclerosis, and percentage of patients treated with a therapy.

The study helps executives estimate Multiple Sclerosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Multiple Sclerosis prevalence, Multiple Sclerosis diagnosis rate, and Multiple Sclerosis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Multiple Sclerosis Patient Flow
  • Multiple Sclerosis Prevalence
  • Multiple Sclerosis Diagnosed Patients
  • Multiple Sclerosis Treated Patients


1. Multiple Sclerosis: Disease Definition
2. Global Multiple Sclerosis Patient Flow
2A. Global Multiple Sclerosis Prevalence
2B. Global Multiple Sclerosis Diagnosed Patients
2C. Global Multiple Sclerosis Treated Patients
3. Multiple Sclerosis Patient Flow in the US
3A. Multiple Sclerosis Prevalence in the US
3B. Multiple Sclerosis Diagnosed Patients in the US
3C. Multiple Sclerosis Treated Patients in the US
4. Multiple Sclerosis Patient Flow in Europe
4A. Multiple Sclerosis Prevalence in Europe
4B. Multiple Sclerosis Diagnosed Patients in Europe
4C. Multiple Sclerosis Treated Patients in Europe
5. Multiple Sclerosis Patient Flow in Germany
5A. Multiple Sclerosis Prevalence in Germany
5B. Multiple Sclerosis Diagnosed Patients in Germany
5C. Multiple Sclerosis Treated Patients in Germany
6. Multiple Sclerosis Patient Flow in France
6A. Multiple Sclerosis Prevalence in France
6B. Multiple Sclerosis Diagnosed Patients in France
6C. Multiple Sclerosis Treated Patients in France
7. Multiple Sclerosis Patient Flow in Spain
7A. Multiple Sclerosis Prevalence in Spain
7B. Multiple Sclerosis Diagnosed Patients in Spain
7C. Multiple Sclerosis Treated Patients in Spain
8. Multiple Sclerosis Patient Flow in Italy
8A. Multiple Sclerosis Prevalence in Italy
8B. Multiple Sclerosis Diagnosed Patients in Italy
8C. Multiple Sclerosis Treated Patients in Italy
9. Multiple Sclerosis Patient Flow in UK
9A. Multiple Sclerosis Prevalence in UK
9B. Multiple Sclerosis Diagnosed Patients in UK
9C. Multiple Sclerosis Treated Patients in UK
10. Multiple Sclerosis Patient Flow in Japan
10A. Multiple Sclerosis Prevalence in Japan
10B. Multiple Sclerosis Diagnosed Patients in Japan
10C. Multiple Sclerosis Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Multiple Sclerosis Patient Flow, 2016
Table 2: Global Multiple Sclerosis Patient Flow Forecast, 2016 - 2025
Table 3: Multiple Sclerosis Patient Flow in the US, 2016
Table 4: Multiple Sclerosis Patient Flow Forecast in the US, 2016 - 2025
Table 5: Multiple Sclerosis Patient Flow in Europe, 2016
Table 6: Multiple Sclerosis Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Multiple Sclerosis Patient Flow in Germany, 2016
Table 8: Multiple Sclerosis Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Multiple Sclerosis Patient Flow in France, 2016
Table 10: Multiple Sclerosis Patient Flow Forecast in France, 2016 - 2025
Table 11: Multiple Sclerosis Patient Flow in Spain, 2016
Table 12: Multiple Sclerosis Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Multiple Sclerosis Patient Flow in Italy, 2016
Table 14: Multiple Sclerosis Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Multiple Sclerosis Patient Flow in UK, 2016
Table 16: Multiple Sclerosis Patient Flow Forecast in UK, 2016 - 2025
Table 17: Multiple Sclerosis Patient Flow in Japan, 2016
Table 18: Multiple Sclerosis Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Multiple Sclerosis Patient Flow, 2016
Figure 2: Global Multiple Sclerosis Patient Flow Forecast, 2016 - 2025
Figure 3: Multiple Sclerosis Patient Flow in the US, 2016
Figure 4: Multiple Sclerosis Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Multiple Sclerosis Patient Flow in Europe, 2016
Figure 6: Multiple Sclerosis Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Multiple Sclerosis Patient Flow in Germany, 2016
Figure 8: Multiple Sclerosis Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Multiple Sclerosis Patient Flow in France, 2016
Figure 10: Multiple Sclerosis Patient Flow Forecast in France, 2016 - 2025
Figure 11: Multiple Sclerosis Patient Flow in Spain, 2016
Figure 12: Multiple Sclerosis Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Multiple Sclerosis Patient Flow in Italy, 2016
Figure 14: Multiple Sclerosis Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Multiple Sclerosis Patient Flow in UK, 2016
Figure 16: Multiple Sclerosis Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Multiple Sclerosis Patient Flow in Japan, 2016
Figure 18: Multiple Sclerosis Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report